Wenxuan Cai1,2, Jianhua Zhang3, Willem J de Lange4, Zachery R Gregorich2,3, Hannah Karp2, Emily T Farrell4, Stanford D Mitchell1,2, Trisha Tucholski1,5,6, Ziqing Lin2,7, Mitch Biermann3, Sean J McIlwain6,8, J Carter Ralphe4, Timothy J Kamp1,2,3, Ying Ge1,2,7,5. 1. From the Molecular and Cellular Pharmacology Training Program (W.C., S.D.M., T.J.K., Y.G.), University of Wisconsin-Madison. 2. Department of Cell and Regenerative Biology (W.C., Z.R.G., H.K., S.D.M., Z.L., T.J.K., Y.G.), University of Wisconsin-Madison. 3. Department of Medicine (J.Z., Z.R.G., M.B., T.J.K.), University of Wisconsin-Madison. 4. Department of Pediatrics (W.J.d.L., E.T.F., J.C.R.), University of Wisconsin-Madison. 5. Department of Chemistry (T.T., Y.G.), University of Wisconsin-Madison. 6. Department of Biostatistics and Medical Informatics (T.T., S.J.M.), University of Wisconsin-Madison. 7. Human Proteomics Program (Z.L., Y.G.), University of Wisconsin-Madison. 8. UW Carbone Cancer Center (S.J.M.), University of Wisconsin-Madison.
Abstract
RATIONALE: Human pluripotent stem cell (hPSC)-derived cardiomyocytes exhibit the properties of fetal cardiomyocytes, which limits their applications. Various methods have been used to promote maturation of hPSC-cardiomyocytes; however, there is a lack of an unbiased and comprehensive method for accurate assessment of the maturity of hPSC-cardiomyocytes. OBJECTIVE: We aim to develop an unbiased proteomics strategy integrating high-throughput top-down targeted proteomics and bottom-up global proteomics for the accurate and comprehensive assessment of hPSC-cardiomyocyte maturation. METHODS AND RESULTS: Utilizing hPSC-cardiomyocytes from early- and late-stage 2-dimensional monolayer culture and 3-dimensional engineered cardiac tissue, we demonstrated the high reproducibility and reliability of a top-down proteomics method, which enabled simultaneous quantification of contractile protein isoform expression and associated post-translational modifications. This method allowed for the detection of known maturation-associated contractile protein alterations and, for the first time, identified contractile protein post-translational modifications as promising new markers of hPSC-cardiomyocytes maturation. Most notably, decreased phosphorylation of α-tropomyosin was found to be associated with hPSC-cardiomyocyte maturation. By employing a bottom-up global proteomics strategy, we identified candidate maturation-associated markers important for sarcomere organization, cardiac excitability, and Ca2+ homeostasis. In particular, upregulation of myomesin 1 and transmembrane 65 was associated with hPSC-cardiomyocyte maturation and validated in cardiac development, making these promising markers for assessing maturity of hPSC-cardiomyocytes. We have further validated α-actinin isoforms, phospholamban, dystrophin, αB-crystallin, and calsequestrin 2 as novel maturation-associated markers, in the developing mouse cardiac ventricles. CONCLUSIONS: We established an unbiased proteomics method that can provide accurate and specific assessment of the maturity of hPSC-cardiomyocytes and identified new markers of maturation. Furthermore, this integrated proteomics strategy laid a strong foundation for uncovering the molecular pathways involved in cardiac development and disease using hPSC-cardiomyocytes.
RATIONALE: Human pluripotent stem cell (hPSC)-derived cardiomyocytes exhibit the properties of fetal cardiomyocytes, which limits their applications. Various methods have been used to promote maturation of hPSC-cardiomyocytes; however, there is a lack of an unbiased and comprehensive method for accurate assessment of the maturity of hPSC-cardiomyocytes. OBJECTIVE: We aim to develop an unbiased proteomics strategy integrating high-throughput top-down targeted proteomics and bottom-up global proteomics for the accurate and comprehensive assessment of hPSC-cardiomyocyte maturation. METHODS AND RESULTS: Utilizing hPSC-cardiomyocytes from early- and late-stage 2-dimensional monolayer culture and 3-dimensional engineered cardiac tissue, we demonstrated the high reproducibility and reliability of a top-down proteomics method, which enabled simultaneous quantification of contractile protein isoform expression and associated post-translational modifications. This method allowed for the detection of known maturation-associated contractile protein alterations and, for the first time, identified contractile protein post-translational modifications as promising new markers of hPSC-cardiomyocytes maturation. Most notably, decreased phosphorylation of α-tropomyosin was found to be associated with hPSC-cardiomyocyte maturation. By employing a bottom-up global proteomics strategy, we identified candidate maturation-associated markers important for sarcomere organization, cardiac excitability, and Ca2+ homeostasis. In particular, upregulation of myomesin 1 and transmembrane 65 was associated with hPSC-cardiomyocyte maturation and validated in cardiac development, making these promising markers for assessing maturity of hPSC-cardiomyocytes. We have further validated α-actinin isoforms, phospholamban, dystrophin, αB-crystallin, and calsequestrin 2 as novel maturation-associated markers, in the developing mouse cardiac ventricles. CONCLUSIONS: We established an unbiased proteomics method that can provide accurate and specific assessment of the maturity of hPSC-cardiomyocytes and identified new markers of maturation. Furthermore, this integrated proteomics strategy laid a strong foundation for uncovering the molecular pathways involved in cardiac development and disease using hPSC-cardiomyocytes.
Entities:
Keywords:
heart; mass spectrometry; pluripotent stem cells; proteomics; troponin
Authors: Cathelijne W van den Berg; Satoshi Okawa; Susana M Chuva de Sousa Lopes; Liesbeth van Iperen; Robert Passier; Stefan R Braam; Leon G Tertoolen; Antonio del Sol; Richard P Davis; Christine L Mummery Journal: Development Date: 2015-07-24 Impact factor: 6.868
Authors: Christine L Mummery; Jianhua Zhang; Elizabeth S Ng; David A Elliott; Andrew G Elefanty; Timothy J Kamp Journal: Circ Res Date: 2012-07-20 Impact factor: 17.367
Authors: Terri A Pietka; Matthew S Sulkin; Ondrej Kuda; Wei Wang; Dequan Zhou; Kathryn A Yamada; Kui Yang; Xiong Su; Richard W Gross; Jeanne M Nerbonne; Igor R Efimov; Nada A Abumrad Journal: J Biol Chem Date: 2012-09-27 Impact factor: 5.157
Authors: Jianding Cheng; David W Van Norstrand; Argelia Medeiros-Domingo; Carmen Valdivia; Bi-hua Tan; Bin Ye; Stacie Kroboth; Matteo Vatta; David J Tester; Craig T January; Jonathan C Makielski; Michael J Ackerman Journal: Circ Arrhythm Electrophysiol Date: 2009-12
Authors: Zachery R Gregorich; Ying Peng; Wenxuan Cai; Yutong Jin; Liming Wei; Albert J Chen; Susan H McKiernan; Judd M Aiken; Richard L Moss; Gary M Diffee; Ying Ge Journal: J Proteome Res Date: 2016-07-13 Impact factor: 4.466
Authors: Willem J de Lange; Emily T Farrell; Caroline R Kreitzer; Derek R Jacobs; Di Lang; Alexey V Glukhov; J Carter Ralphe Journal: Am J Physiol Heart Circ Physiol Date: 2021-02-19 Impact factor: 4.733
Authors: Jake A Melby; David S Roberts; Eli J Larson; Kyle A Brown; Elizabeth F Bayne; Song Jin; Ying Ge Journal: J Am Soc Mass Spectrom Date: 2021-05-13 Impact factor: 3.109
Authors: Jake A Melby; Willem J de Lange; Jianhua Zhang; David S Roberts; Stanford D Mitchell; Trisha Tucholski; Gina Kim; Andreas Kyrvasilis; Sean J McIlwain; Timothy J Kamp; J Carter Ralphe; Ying Ge Journal: J Proteome Res Date: 2021-01-04 Impact factor: 4.466
Authors: Asher Kahn-Krell; Danielle Pretorius; Jianfa Ou; Vladimir G Fast; Silvio Litovsky; Joel Berry; Xiaoguang Margaret Liu; Jianyi Zhang Journal: Front Bioeng Biotechnol Date: 2021-06-11